drug

Anticholinergic Deprescription

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Deepak K. Sarpal, M.D.
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Anticholinergic Deprescription in Schizophrenia
NCT06562608Phase 4Recruiting

KOLs & investigators

1
Deepak C D'Souza, M.D.KOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Deepak K. Sarpal, M.D.
company
trial
Anticholinergic Deprescription in Schizophrenia
PHASE4
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
KOL
Deepak C D'Souza, M.D.
KOL score 5
person